Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis (AD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01979016
What this trial is testing

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis (AD)
Regeneron Pharmaceuticals 54
Large-scale testing (Phase 3)Study completedNCT03269773
What this trial is testing

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 197
Large-scale testing (Phase 3)Active Not RecruitingNCT06241118
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Who this might be right for
Dermatitis Atopic
Sanofi 464
Testing effectiveness (Phase 2)Active Not RecruitingNCT06136741
What this trial is testing

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Nektar Therapeutics 396
Not applicableActive Not RecruitingNCT05139836
What this trial is testing

Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting

Who this might be right for
Atopic Dermatitis
AbbVie 634
Not applicableActive Not RecruitingNCT05669794
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

Who this might be right for
Atopic Dermatitis
AbbVie 300
Testing effectiveness (Phase 2)Ended earlyNCT05155085
What this trial is testing

Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Allakos Inc. 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT07011706
What this trial is testing

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+2 more
Aclaris Therapeutics, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT07186387
What this trial is testing

Study of LW402 in Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Shanghai Longwood Biopharmaceuticals Co., Ltd. 144
Early research (Phase 1)Looking for participantsNCT07453602
What this trial is testing

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Who this might be right for
Atopic Dermatitis (AD)Eczema
Arcutis Biotherapeutics, Inc. 125
Large-scale testing (Phase 3)Looking for participantsNCT07042126
What this trial is testing

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 180
Early research (Phase 1)Study completedNCT06945458
What this trial is testing

Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Kymera Therapeutics, Inc. 22
Not applicableStudy completedNCT02226068
What this trial is testing

Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University of Aarhus 20
Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Post-approval studies (Phase 4)UnknownNCT06465732
What this trial is testing

Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients

Who this might be right for
Atopic Dermatitis
Second Affiliated Hospital, Zhejiang University, School of Medicine 220
Large-scale testing (Phase 3)Study completedNCT05899816
What this trial is testing

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic Dermatitis
Amgen 221
Testing effectiveness (Phase 2)Active Not RecruitingNCT04137562
What this trial is testing

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 118
Testing effectiveness (Phase 2)Study completedNCT06723405
What this trial is testing

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)EczemaEczema Atopic Dermatitis
Evommune, Inc. 71
Testing effectiveness (Phase 2)Study completedNCT04893941
What this trial is testing

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 39
Testing effectiveness (Phase 2)UnknownNCT02365246
What this trial is testing

Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)

Who this might be right for
Atopic Dermatitis
Universitaire Ziekenhuizen KU Leuven 15
Next Page